AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, C.
Right arrow Articles by Dart, A. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, C.
Right arrow Articles by Dart, A. M
Agricola
Right arrow Articles by Williams, C.
Right arrow Articles by Dart, A. M
American Journal of Clinical Nutrition, Vol. 82, No. 1, 26-31, July 2005
© 2005 American Society for Clinical Nutrition


ORIGINAL RESEARCH COMMUNICATION

Folic acid supplementation for 3 wk reduces pulse pressure and large artery stiffness independent of MTHFR genotype1,2,3

Carolyn Williams, Bronwyn A Kingwell, Kevin Burke, Jane McPherson and Anthony M Dart

1 From the Baker Heart Research Institute, Melbourne, Australia

Background: Folic acid reduces plasma homocysteine and may be an important therapy for preventing cardiovascular disease. A key mechanism may be the reduction of arterial stiffness.

Objective: The effect of folic acid supplementation on blood pressure and large artery stiffness was examined in relation to methylenetetrahydrofolate reductase (MTHFR) genotype.

Design: Forty-one asymptomatic men with normal or high-normal ambulatory blood pressure (systolic: >130 to <145 mm Hg; diastolic: >80 to <90 mm Hg) participated. The study had a randomized, placebo-controlled, double-blind, crossover design that incorporated 3-wk treatments with 5 mg folic acid/d or matching placebo; each treatment was separated by a 4-wk washout phase.

Results: Folic acid reduced brachial pulse pressure by 4.7 ± 1.6 mm Hg (P < 0.05) without changing mean arterial pressure. Systemic arterial compliance increased by 0.15 ± 0.03 mL/mm Hg (P < 0.05) after folic acid treatment but did not change after placebo treatment. These responses did not significantly correlate with either homocysteine or folate plasma concentrations. MTHFR genotype CC homozygotes (without the 677C->T polymorphism) with normal blood pressure had a larger reduction in homocysteine concentrations in response to folic acid than did T allele carriers. Blood pressure and arterial stiffness responses were independent of MTHFR genotype.

Conclusion: Folic acid is a safe and effective supplement that targets large artery stiffness and may prevent isolated systolic hypertension.

Key Words: Homocysteine • genetics • MTHFR gene • folate therapy • arterial stiffness • pulse pressure • hypertension




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. L. Moens, C. J. Vrints, M. J. Claeys, J.-P. Timmermans, H. C. Champion, and D. A. Kass
Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H1971 - H1977.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. M. Dart, J. D. Cameron, C. D. Gatzka, K. Willson, Y.-L. Liang, K. L. Berry, L. M.H. Wing, C. M. Reid, P. Ryan, L. J. Beilin, et al.
Similar Effects of Treatment on Central and Brachial Blood Pressures in Older Hypertensive Subjects in the Second Australian National Blood Pressure Trial
Hypertension, June 1, 2007; 49(6): 1242 - 1247.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. A. McMahon, C. M. Skeaff, S. M. Williams, and T. J. Green
Lowering Homocysteine with B Vitamins Has No Effect on Blood Pressure in Older Adults
J. Nutr., May 1, 2007; 137(5): 1183 - 1187.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Shirodaria, C. Antoniades, J. Lee, C. E. Jackson, M. D. Robson, J. M. Francis, S. J. Moat, C. Ratnatunga, R. Pillai, H. Refsum, et al.
Global Improvement of Vascular Function and Redox State With Low-Dose Folic Acid: Implications for Folate Therapy in Patients With Coronary Artery Disease
Circulation, May 1, 2007; 115(17): 2262 - 2270.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. E. Mullick, U. B. Zaid, C. N. Athanassious, S. R. Lentz, J. C. Rutledge, and J. D. Symons
Hyperhomocysteinemia increases arterial permeability and stiffness in mice
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1349 - R1354.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
H. A. Bischoff, H. B. Staehelin, and W. C. Willett
The effect of undernutrition in the development of frailty in older persons.
J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2006; 61(6): 585 - 589.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. D. Symons, U. B. Zaid, C. N. Athanassious, A. E. Mullick, S. R. Lentz, and J. C. Rutledge
Influence of Folate on Arterial Permeability and Stiffness in the Absence or Presence of Hyperhomocysteinemia
Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 814 - 818.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by The American Society for Nutrition